| AI/ML | Sam Hadlington | sam.hadlington@plus-project.co.uk |
| AIMS | Martin Brown | Martin.Brown1@thermofisher.com |
| Benefit Risk | Shahrul Mt-Isa & Marco Boeri | shahrul.mt-isa@msd.com;
marcoboeri@openhealthgroup.com
|
| Biomarkers | Mathias Cardner & Schlieker | mathias.cardner1@astrazeneca.com;
schlieker@staburo.de
|
| Causal Inference | Sanne Roels & Kelly Van Lancker | sroels4@its.jnj.com;
kelly.vanlancker@ugent.be
|
| CMC | Kevin R. Lief | kevin.r.lief@gsk.com |
| CSM/QTL | Tim Rolfe & Susan Talbot | timothy.e.rolfe@gsk.com;
susan.talbot@amgen.com
|
| Data Science | Carsten Henneges | Carsten.Henneges@sanofi.com
|
| Data Sharing | Rebecca Sudlow | rebecca.sudlow@googlemail.com;
|
| Early Phase | Sam Hinsley & Marie-Karelle Riviere | samantha.hinsley@phastar.com;
marie-karelle.riviere@saryga.com
|
|
| Historical Data | Nicky Best & Simon Wandel | nicky.x.best@gsk.com;
simon.wandel@novartis.com
|
| HTA | Ursula Becker, Arthur Allignol, Katrin Kupas | htasig@psiweb.org
|
| Launch & Lifecycle | Jenny Devenport; Yulia Dyachkova | jenny.devenport@merckgroup.com;
yulia.dyachkova@merckgroup.com
|
| Medical Devices | Michael Mader | michael.mader@envistaco.com |
| Neuroscience-Estimands | Paul Delmar | paul.delmar@roche.com |
| Oncology Estimands | Oncology Estimand Working Group | www.oncoestimand.org |
| Openstatsware | Alessandro Gasparini & Daniel Sabanés Bové | alessandro.gasparini@reddooranalytics.se;
daniel.sabanes_bove@rconis.com
|
| Patient Focused Drug Development (PFDD) | Rachael Lawrance & Konstantina Skaltsa | rachael.lawrance@adelphivalues.com;
konstantina.skaltsa@iqvia.com
|
| Pre-Clinical | Eloisa I. Brook | eloisa.i.brook@gsk.com |
| Quantitative Decision Making | Corine Baayen | coba@lundbeck.com
|
| Randomisation | Johannes Krisam & Annika Scheffold | johannes.krisam@boehringer-ingelheim.com;
annika.scheffold@boehringer-ingelheim.com
|
| Real World Data (RWD) | Josephine Wolfram & Eleanor Ralphs | Josephine.Wolfram@astellas.com;
eleanor.ralphs@iqvia.com
|
| Regulatory | Yolanda Barbachano & Fredrik Öhrn | yolanda.barbachano@biontech.co.uk;
FOhrn@ITS.JNJ.com
|
| Small Populations | Tal X. Otiker; Aysun Cetinyurek-Yavuz | tal.x.otiker@gsk.com;
aysun.cetinyurek-yavuz@radboudumc.nl
|
| Treatment Effect Heterogeneity | David J. Svensson | david.j.svensson@astrazeneca.com |
| Vaccines | Fabian S. Tibaldi | fabian.s.tibaldi@gsk.com |
| Visualisation | Bodo Kirsch | kirschbodo@gmail.com |